Evidence map›Paper›PMID 22048243›Full record

ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2012

Effects of all-trans retinoic acid nanoparticles on corneal epithelial wound healing.

Masako Hattori, Kazuhiro Shimizu, Kozo Katsumura, Hidehiro Oku, Yoichiro Sano, Kayo Matsumoto, Yoko Yamaguchi, Tsunehiko Ikeda

Abstract read
PubMed Publisher
In one paragraph

Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. 1,25-dihydroxyvitamin D3 inhibits corneal wound healing in an ex-vivo mouse model.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2016
    Article
  5. Progress in corneal wound healing.Progress in retinal and eye research · 2015
    Review
  6. Article
  7. Article
  8. Article
  9. Nanoparticles in the ocular drug delivery.International journal of ophthalmology · 2013
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Masako HattoriDepartment of Ophthalmology, Osaka Medical College, 2-7 Daigaku-machi, 569-8686, Takatsuki, Osaka, Japan.
Kazuhiro Shimizu
Kozo Katsumura
Hidehiro Oku
Yoichiro Sano
Kayo Matsumoto
Yoko Yamaguchi
Tsunehiko Ikeda
Osaka Medical and Pharmaceutical University · JPSt. Marianna University School of Medicine · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe have developed inorganically-coated all-trans retinoic acid (atRA) nanoparticles, nano-sized egg-like particles of atRA (NANOEGG®-atRA). The purpose of this study was to determine the effects of NANOEGG®-atRA on corneal wound healing in vivo and in vitro.

methodsA rabbit corneal epithelial wound healing model was exposed to different concentrations of NANOEGG®-atRA. Wound healing was serially quantified as the ratio of fluorescein-stained area at the selected times to that at baseline. After wound closure, the barrier function of the cornea was determined using low concentrations of tropicamide. At the completion of the experiments, the corneal epithelium was histologically examined. For the in vitro studies, linear scratch wounds were made on cultured SV40-immortalized human corneal epithelial cells (HCE-T). Then, the cells were exposed to different concentrations of NANOEGG®-atRA, and wound healing was determined by the degree of closure of the scratch wound. In addition, the effects of NANOEGG®-atRA on the proliferation of HCE-T cells were determined by WST-8 assays.

resultsExposure to NANOEGG®-atRA decreased the injured area 24 hrs after the ablation. The maximum effect of NANOEGG®-atRA was observed at a concentration of 33 mM. Histologically, no abnormal or differentiated corneal epithelial cells were observed in the histological sections treated with NANOEGG®-atRA. The tropicamide-induced pupillary dilation was significantly slowed in the eyes treated with NANOEGG®-atRA. NANOEGG®-atRA at concentrations of 3.3 and 33 nM induced earlier wound closure in vitro, but did not induce proliferation of HCE-T cells.

conclusionNANOEGG®-atRA promotes wound healing and should be considered for the treatment of wounds of the corneal epithelium.

Indexed as

Disease Models, AnimalAnimalsBiological TransportCell MovementCell ProliferationCells, CulturedCorneaCorneal InjuriesDrug CarriersEpithelium, CornealFluorophotometryKeratolytic AgentsMaleMembrane ProteinsNanoparticlesOccludinDrug CarriersKeratolytic AgentsMembrane ProteinsOccludinOCLN protein, humanPhosphoproteinsTJP1 protein, humanTretinoinZonula Occludens-1 Protein

Identifiers

PMID22048243
OpenAlexW2095565731

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.